Publicaciones en las que colabora con SARA PANIZO GARCIA (29)

2024

  1. Novel Biomarkers of Bone Metabolism

    Nutrients, Vol. 16, Núm. 5

  2. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

  2. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  3. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740

  4. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  5. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

    Nutrients, Vol. 15, Núm. 13

  6. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

  7. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  8. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

2022

  1. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

    BMC medicine, Vol. 20, Núm. 1, pp. 83

  2. Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

    Nutrients, Vol. 14, Núm. 13

2021

  1. Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure

    Nefrologia, Vol. 41, Núm. 6, pp. 640-651

  2. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  3. Fibrosis in chronic kidney disease: Pathogenesis and consequences

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-19

  4. Pathophysiology of vascular calcification and bone loss: Linked disorders of ageing?

    Nutrients, Vol. 13, Núm. 11

  5. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 439-451

  6. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 4, pp. 618-631

2019

  1. Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition

    Scientific Reports, Vol. 9, Núm. 1

  2. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 6, pp. 934-941